OrthoPediatrics Corp. (KIDS) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $30.94 (-1.89%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Oct 29, 2025 | Mike Matson | Needham | $26.00 | -16.0% |
| Oct 10, 2025 | Richard Newitter | Truist Financial | $18.00 | -41.8% |
| Oct 10, 2025 | David Turkaly | JMP Securities | $25.00 | -19.2% |
| Oct 10, 2025 | Rick Wise | Stifel Nicolaus | $20.00 | -35.4% |
| Oct 10, 2025 | Matt O'Brien | Piper Sandler | $22.00 | -28.9% |
| Aug 8, 2025 | David Turkaly | JMP Securities | $35.00 | +13.1% |
| Oct 14, 2024 | Richard Newitter | Truist Financial | $28.00 | -9.5% |
| Sep 13, 2024 | Mike Matson | Needham | $42.00 | +35.7% |
| Sep 13, 2024 | Kaila Krum | Truist Financial | $34.00 | +9.9% |
| Sep 6, 2024 | Matt O'Brien | Piper Sandler | $44.00 | +42.2% |
| Sep 6, 2024 | Ryan Zimmerman | BTIG | $44.00 | +42.2% |
| Jul 16, 2024 | Richard Newitter | Truist Financial | $35.00 | +13.1% |
| May 7, 2024 | Rick Wise | Stifel Nicolaus | $40.00 | +29.3% |
Top Analysts Covering KIDS
KIDS vs Sector & Market
| Metric | KIDS | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.17 | 2.25 | 2.41 |
| Analyst Count | 12 | 8 | 19 |
| Target Upside | -2.1% | +153002.0% | +21.5% |
| P/E Ratio | -9.00 | 3.48 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $264M | $264M | $265M | 6 |
| 2027-03-31 | $64M | $65M | $66M | 2 |
| 2027-06-30 | $75M | $76M | $77M | 2 |
| 2027-09-30 | $76M | $77M | $78M | 2 |
| 2027-12-31 | $76M | $77M | $77M | 2 |
| 2028-03-31 | $72M | $73M | $73M | 1 |
| 2028-06-30 | $86M | $87M | $88M | 1 |
| 2028-09-30 | $86M | $87M | $88M | 1 |
| 2028-12-31 | $85M | $86M | $87M | 1 |
| 2029-12-31 | $368M | $369M | $370M | 1 |
| 2030-12-31 | $410M | $411M | $413M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-1.18 | $-1.17 | $-1.17 | 5 |
| 2027-03-31 | $-0.29 | $-0.29 | $-0.28 | 1 |
| 2027-06-30 | $-0.15 | $-0.15 | $-0.14 | 1 |
| 2027-09-30 | $-0.06 | $-0.06 | $-0.06 | 1 |
| 2027-12-31 | $-0.13 | $-0.12 | $-0.12 | 1 |
| 2028-03-31 | $0.00 | $0.00 | $0.00 | 1 |
| 2028-06-30 | $0.00 | $0.00 | $0.00 | 1 |
| 2028-09-30 | $0.00 | $0.00 | $0.00 | 1 |
| 2028-12-31 | $0.00 | $0.00 | $0.00 | 1 |
| 2029-12-31 | $-0.01 | $-0.01 | $-0.01 | 1 |
| 2030-12-31 | $0.48 | $0.48 | $0.48 | 1 |
Frequently Asked Questions
What is the analyst consensus for KIDS?
The consensus among 12 analysts covering OrthoPediatrics Corp. (KIDS) is Buy with an average price target of $25.25.
What is the highest price target for KIDS?
The highest price target for KIDS is $44.00, set by Matt O'Brien at Piper Sandler on 2024-09-06.
What is the lowest price target for KIDS?
The lowest price target for KIDS is $18.00, set by Richard Newitter at Truist Financial on 2025-10-10.
How many analysts cover KIDS?
12 analysts have issued ratings for OrthoPediatrics Corp. in the past 12 months.
Is KIDS a buy or sell right now?
Based on 12 analyst ratings, KIDS has a consensus rating of Buy (2.17/5) with a -2.1% upside to the consensus target of $25.25.
What are the earnings estimates for KIDS?
Analysts estimate KIDS will report EPS of $-1.17 for the period ending 2026-12-31, with revenue estimated at $264M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.